Philippines' Food and Drug Administration (FDA) has approved Chinese TCM Lianhua Qingwen capsules to treat Covid19 infection. In a study of 284 patients with mild and moderate COVID-19 symptoms at 23 hospitals across nine provinces, the drug showed that drug treatment of 14 days led to a higher rate of recovery for mild and moderate cases, in that it helped reduce the proportion of mild cases developing into severe cases and shortened the duration in which patients go from testing positive to testing negative.
So far, Lianhua Qingwen has made inroads into eight countries and two regions under different categories, including Chinese medicine, Chinese patent drug, botanical drug products, dietary supplement, and food additive, among others.
